Article
Looking to solve the solid tumor puzzle box, Carisma aims to take 'CAR-M' groundbreaker into early-
Rating:
0.0
Views:
79
Likes:
1
Library:
1
In an effort to crack the code of hard-to-treat solid tumors, biopharma has tried numerous pathways to effectively target those masses without damaging healthy tissues. Philly's Carisma Therapeutics thinks it has a winner with its macrophage cell-based
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value